Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 110529572 | 11052957 | 2 | F | 20160912 | 20150421 | 20160920 | EXP | CA-OTSUKA-US-2014-11869 | OTSUKA | 0.00 | M | Y | 0.00000 | 20160920 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 110529572 | 11052957 | 1 | PS | ARIPIPRAZOLE. | ARIPIPRAZOLE | 1 | Unknown | 400 MG, UNK | U | 202971 | 400 | MG | SUSPENSION FOR INJECTION | ||||||
| 110529572 | 11052957 | 2 | SS | ARIPIPRAZOLE. | ARIPIPRAZOLE | 1 | U | 202971 | SUSPENSION FOR INJECTION | ||||||||||
| 110529572 | 11052957 | 3 | SS | ARIPIPRAZOLE. | ARIPIPRAZOLE | 1 | U | 202971 | SUSPENSION FOR INJECTION | ||||||||||
| 110529572 | 11052957 | 4 | SS | ARIPIPRAZOLE. | ARIPIPRAZOLE | 1 | U | 202971 | SUSPENSION FOR INJECTION | ||||||||||
| 110529572 | 11052957 | 5 | SS | ABILIFY | ARIPIPRAZOLE | 1 | Oral | UNK | Y | 0 | TABLET | ||||||||
| 110529572 | 11052957 | 6 | SS | ABILIFY | ARIPIPRAZOLE | 1 | Unknown | UNK | U | 202971 | SUSPENSION FOR INJECTION | ||||||||
| 110529572 | 11052957 | 7 | SS | ABILIFY | ARIPIPRAZOLE | 1 | Oral | UNK | Y | 0 | |||||||||
| 110529572 | 11052957 | 8 | SS | LAMOTRIGINE. | LAMOTRIGINE | 1 | Unknown | UNK | U | 0 | |||||||||
| 110529572 | 11052957 | 9 | C | ATIVAN | LORAZEPAM | 1 | Unknown | 0.5 MG, PRN | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 110529572 | 11052957 | 1 | Schizophrenia |
| 110529572 | 11052957 | 2 | Dissociative identity disorder |
| 110529572 | 11052957 | 3 | Borderline personality disorder |
| 110529572 | 11052957 | 4 | Narcissistic personality disorder |
| 110529572 | 11052957 | 5 | Schizophrenia |
| 110529572 | 11052957 | 6 | Schizophrenia |
| 110529572 | 11052957 | 7 | Schizophrenia |
| 110529572 | 11052957 | 8 | Product used for unknown indication |
| 110529572 | 11052957 | 9 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 110529572 | 11052957 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 110529572 | 11052957 | Affective disorder | |
| 110529572 | 11052957 | Anger | |
| 110529572 | 11052957 | Mood altered | |
| 110529572 | 11052957 | Off label use | |
| 110529572 | 11052957 | Paranoia | |
| 110529572 | 11052957 | Rash |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |